Cobra Biologics and Pharmaceutical Services Cobra provides a comprehensive biologics and pharmaceuticals service offering, with multi-functional and experienced project teams nurturing customers’ products from pre-clinical through to clinical and commercial manufacture within GMP approved facilities. Latest News View all Cobra Biologics Expands DNA Vaccines, Gene And Immunotherapy Production In Sweden With €20m Plant 29th Mar 2019 Room For Improvement: Tackling Sub-Optimal Downstream Process Unit Operations For Viral Vectors 22nd Mar 2019 Cobra Biologics appoints Dr Darrell Sleep as Director of Innovation 15th Jan 2019 HQ Plasmid Slots Now Available Our High Quality (HQ) offering adopts features of Cobra’s GMP manufacture with a 6 week delivery time. Find Out More & Get In Touch Today Cobra Biologics Receives the Queen’s Award for Enterprise in International Trade The UK’s most prestigious business award granted in recognition of outstanding achievement in the export of services for gene and immunotherapy products. Find Out More Our Awards Get In Touch Speak to a member of our expert team and arrange to take a tour of our GMP facilities in the UK and Sweden. Contact Us About Cobra Biologics Cobra Biologics is a leading international contract development and manufacturing organisation (CDMO) providing biologics and pharmaceuticals for pre-clinical, clinical and commercial supply. 2 GMP approved facilities 320+ products released for clinical trials 18 Countries serviced @CobraBiologics yesterday We're having a great time at the 6th Microbiome R&D & Business Collaboration Forum! You can find our friendly team… https://t.co/1aALHyHypg 2 days ago Join Cobra at this year's BIO convention, taking place in Philadelphia, PA! Click here to pre-arrange to meet our f… https://t.co/8EElUB45H7 2 days ago The Cobra team are in #Rotterdam today for the Microbiome R&D Business Collaboration Forum! Drop by booth 24 for an… https://t.co/eMzhohMMx4 Sign up to receive news and more Keep up to date with the latest news from Cobra Biologics Newsletter signup Name Email
Cobra Biologics Expands DNA Vaccines, Gene And Immunotherapy Production In Sweden With €20m Plant 29th Mar 2019
Room For Improvement: Tackling Sub-Optimal Downstream Process Unit Operations For Viral Vectors 22nd Mar 2019